Breast Health

July 08, 2020

New research shows that, in postmenopausal women undergoing hormone therapy for breast cancer, aromatase inhibitors (AIs) lead to a reduction in climacteric symptoms and significantly improved quality of life.

June 23, 2020

Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.

June 12, 2020

Findings from a new study show significant overall survival benefit of Novartis’ ribociclib in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer with visceral metastases.

June 04, 2020

Long-term adherence improvements, it appears, require personalized and sustained behavioral interventions. TMs for AI should also be personalized for individual success.

October 29, 2019

The agency issued the guidance in response to concerns that some women are not receiving and/or understanding information about the risks and benefits of the devices.

October 03, 2019

Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration. 

February 20, 2019

A recent study aimed to quantify the effectiveness of improvements in screening and treatment.

December 10, 2018

Mammography is just one tool that ob/gyns should be using for breast cancer prevention and risk stratification.

December 07, 2018

An examination of ACOG’s updated guidelines on breast cancer screening recommendations for the average-risk woman.

December 07, 2018

Providing lactating mothers with accurate information on the effects of alcohol consumption is crucial even though data in this area are limited.